2023 Annual Meeting | C114 - Epilepsy Therapy Update

Date Tuesday 04/25/23

Time 07:00 AM - 09:00 AM EST Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Anteneh M. Feyissa, MD, MSc, FAAN

Topic(s) Epilepsy/Clinical Neurophysiology (EEG)

Learning Objectives Participants should become familiar with all currently approved antiseizure medications in the US and how to tailor each drug to the correct patient with seizures; be aware of all surgical modalities, including minimally invasive therapies; and become familiar with neuromodulatory devices for the treatment of epilepsy, including responsive neurostimulation and deep brain stimulation.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Program Level Intermediate

Program Tracks Advanced Practice Provider

Recommended Audience Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Medical Student

Teaching Styles Didactic

Event Timeline
07:00 AM - 07:05 AM EST	Introduction	Introduction Anteneh M. Feyissa, MD, MSc, FAAN
07:05 AM - 07:35 AM EST	Speaker	Update in Antiseizure Medication Therapy Anteneh M. Feyissa, MD, MSc, FAAN
07:35 AM - 08:05 AM EST	Speaker	Update in Neuromodulation Therapy for Epilepsy Vikram Rao, MD
08:05 AM - 08:35 AM EST	Speaker	Update in Epilepsy Surgery Stephan Schuele, MD, FAAN
08:35 AM - 09:00 AM EST	Discussion	Questions and Answers Anteneh M. Feyissa, MD, MSc, FAAN, Vikram Rao, MD, Stephan Schuele, MD, FAAN

Faculty Disclosures
Anteneh M. Feyissa, MD, MSc, FAAN	Dr. Feyissa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurelis.
Vikram Rao, MD	Dr. Rao has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for LivaNova. Dr. Rao has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Rao has stock in Novela Neurotechnologies. Dr. Rao has stock in EnlitenAI. The institution of Dr. Rao has received research support from NeuroPace, Inc.. The institution of Dr. Rao has received research support from Medtronic.
Stephan Schuele, MD, FAAN	Dr. Schuele has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Monteris. Dr. Schuele has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurelis. Dr. Schuele has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Science. Dr. Schuele has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Jazz. Dr. Schuele has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Neurophysiology. Dr. Schuele has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Thomas Needham. Dr. Schuele has received research support from National Institute of Health.